Voyager Therapeutics Inc (NASDAQ:VYGR) price on Thursday, July 03, remained unchanged to $3.2.
A look at the stock’s price movement, the close in the last trading session was $3.2, moving within a range at $3.165 and $3.2799. The beta value (5-Year monthly) was 0.819. Turning to its 52-week performance, $9.55 and $2.64 were the 52-week high and 52-week low respectively. Overall, VYGR moved -2.44% over the past month.
Voyager Therapeutics Inc’s market cap currently stands at around $177.08 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-06.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VYGR is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend VYGR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VYGR’s current price about 0.31% and -1.28% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.89, while 7-day volatility ratio is 6.58% and 6.98% in the 30-day chart. Further, Voyager Therapeutics Inc (VYGR) has a beta value of 0.90. Analysts have given the company’s stock an average 52-week price target of $10, forecast between a low of $10 and high of $10. Looking at the price targets, the low is -212.5% off current price level while to achieve the yearly target high, price needs to move -212.5%. Nonetheless, investors will most likely welcome a -212.5% jump to $10 which is the analysts’ median price.
If we refocus on Voyager Therapeutics Inc (NASDAQ:VYGR), historical trading data shows that trading volumes averaged 0.68 over the past 10 days and 566.09K over the past 3 months. The company’s latest data on shares outstanding shows there are 55.21 million shares.
The 18.69% of Voyager Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 62.86% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.92 million on 2025-06-13, giving us a short ratio of 5.34. The data shows that as of 2025-06-13 short interest in Voyager Therapeutics Inc (VYGR) stood at 845.0000000000001 of shares outstanding, with shares short rising to 2.81 million registered in 2025-05-15. Current price change has pushed the stock -59.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VYGR stock continues to rise going into the next quarter.
